A Real World Study of Paxlovid for the Treatment of Hospitalized Patients Confirmed With COVID-19

Evaluation of the Safety and Efficacy of Azvudine and Paxlovid in the Treatment of Hospitalized Patients With COVID-19

NCT05996770 ·Status: NOT_YET_RECRUITING

The Real-world Clinical Study of Azvudine Tablets in the Treatment of COVID-19

NCT06349655 ·Status: COMPLETED

COVID-19 Breakthrough Infection in Fully Vaccinated People and in People Who Received a Booster Dose

NCT05392075 ·Status: COMPLETED

Efficiency and Safety of Paxlovid for COVID-19 Patients With Severe Chronic Kidney Disease

NCT05938140 ·Status: UNKNOWN ·Phase: PHASE4

A Study on Paxlovid Once in the Market, to Observe Its Safety and Effectiveness in Patients Who Have a High Chance of Getting Severe COVID-19

NCT05890612 ·Status: RECRUITING

A Real-world Retrospective Study of Disease Outcomes in Non-severe COVID-19 Patient

NCT05489874 ·Status: UNKNOWN

Paxlovid for Treatment of Long Covid

NCT05576662 ·Status: COMPLETED ·Phase: PHASE2

A Study to Compare QLS1128 With Placebo in Symptomatic Participants With Mild to Moderate COVID-19

NCT05758519 ·Status: UNKNOWN ·Phase: PHASE3

First-In-Human Study To Evaluate Safety, Tolerability, And Pharmacokinetics Following Single Ascending And Multiple Ascending Doses of PF-07304814 In Hospitalized Participants With COVID-19.

NCT04535167 ·Status: COMPLETED ·Phase: PHASE1

Effectiveness and Safety of New Oral Antivirals for COVID-19

NCT05894603 ·Status: UNKNOWN

RECOVER-VITAL: Platform Protocol to Measure the Effects of Antiviral Therapies on Long COVID Symptoms

NCT05595369 ·Status: COMPLETED ·Phase: PHASE2

A Phase 2 Study to Evaluate the Efficacy and Safety of QLS1128 Orally in Symptomatic Participants With Mild to Moderate COVID-19

NCT05689203 ·Status: UNKNOWN ·Phase: PHASE2

A Study to Learn About the Study Medicine Paxlovid (Nirmatrelvir + Ritonavir) in Adults Aged 60 and Older Living in Korean Long-term Care Hospitals Who Have COVID-19

NCT07089680 ·Status: NOT_YET_RECRUITING

The Efficacy of Azvudine and Paxlovid in High-risk Patients With COVID-19: A Prospective Randomized Controlled Trial

NCT05642910 ·Status: UNKNOWN ·Phase: NA

Study of HS-10517 in Chinese Adult Participants

NCT05779579 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

Oseltamivir and Baloxavir Marboxil for Prophylaxis Against Influenza Under a Hospital-based Setting

NCT06762587 ·Status: NOT_YET_RECRUITING ·Phase: NA

Efficacy and Safety of JT001 (VV116) Compared With Paxlovid

NCT05341609 ·Status: COMPLETED ·Phase: PHASE3

A Study to Understand the Effect and Safety of the Study Medicine PF-07817883 in Adults Who Have Symptoms of COVID-19 But Are Not Hospitalized

NCT05799495 ·Status: COMPLETED ·Phase: PHASE2

Study of the Safety, Tolerability and Efficacy of NP-101 in Treating High Risk Participants Who Are Covid-19 Positive.

NCT05785390 ·Status: TERMINATED ·Phase: PHASE2

Efficacy and Safety of Molnupiravir (MK-4482) in Non-Hospitalized Adult Participants With COVID-19 (MK-4482-002)

NCT04575597 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Efficacy of PJS-539 for Adult Patients With COVID-19.

NCT05008393 ·Status: COMPLETED ·Phase: PHASE2

The Efficacy and Safety of Azovudine in the Treatment of COVID-19

NCT05675761 ·Status: UNKNOWN

Suraxavir Marboxil And Oseltamivir for Influenza Prophylaxis Under a Hospital-based Setting

NCT07236814 ·Status: RECRUITING ·Phase: PHASE3

Study in Participants With Early Stage Coronavirus Disease 2019 (COVID-19) to Evaluate the Safety, Efficacy, and Pharmacokinetics of Remdesivir Administered by Inhalation

NCT04539262 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Study of WPV01 Compared With Placebo in Patients With Mild/Moderate COVID-19 Infection

NCT05752175 ·Status: COMPLETED ·Phase: PHASE2